MD Magazine® Adds Rare Disease Report® to Online Platform

“We are pleased to announce that Rare Disease Report® has found a new home with MD Mag,” said Michael J. Hennessy Jr., president of MJH Associates, Inc., parent company of MD Magazine®. “We look forward to sharing this with our MD Mag community.”

The online addition of Rare Disease Report® will provide MD Mag with clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, videos, and other content in the rare disease space. Clinicians interested in rare diseases will be treated to MD Mag’s brand of breaking news reporting, up-to-date clinical coverage and expert perspectives.

Here is some of the newest Rare Disease Report® content to appear on MD Mag:

• ALS Gene Expression Atlas Could Provide New Disease Insights
• Benralizumab as a Treatment for Hypereosinophilic Syndromes
• FDA Designates PRM-151 Breakthrough Therapy for Idiopathic Pulmonary Fibrosis

For more information, please visit https://www.MDMag.com or follow us on Twitter (https://twitter.com/MDMagazine) or Facebook (https://www.facebook.com/MDMagNews/).

About MD Magazine®

MD Magazine® is a comprehensive clinical news and information portal that provides physicians and other health care professionals with up-to-date specialty- and disease-specific resources designed to help them deliver better care to patients. Readers have access to breaking news, video interviews with physician experts, in-depth conference coverage, finance and practice management updates, insight, and analysis from physician contributors and other resources. MD Magazine® is part of MJH Associates, Inc., the largest privately held, independent full-service medical media company in the U.S. dedicated to delivering trusted health care news across multiple channels.

View source version on businesswire.com: https://www.businesswire.com/news/home/20190422005392/en/